Ken Rankin

Articles by Ken Rankin

"Reverse Copay" Arrangements Gain Ground Among Rx Payers

ByKen Rankin

October 1st 2004

Employers Are Suspicious of PBM Rx Strategies, NCPA Finds

ByKen Rankin

October 1st 2004

Customs & FDA Cannot Keep Up With Rx Imports, GAO Warns

ByKen Rankin

October 1st 2004

E-Prescribing Legislation Wins Praise from Chain Drug Stores

ByKen Rankin

October 1st 2004

Fake "Canadian Generics" Are Promoted On-Line

ByKen Rankin

October 1st 2004

Independent Pharmacies Show Rising Sales and Profit Margins

ByKen Rankin

September 1st 2004

Vermont to Sue FDA Over Prescription Import Curbs

ByKen Rankin

September 1st 2004

Illinois Pharmacists Fume over State's Mail-Order Rx Rules

ByKen Rankin

September 1st 2004

Rx Vending Machines Make a New England Beachhead

ByKen Rankin

September 1st 2004

Maine Rx Monitoring Program Targets Suspicious Prescribing

ByKen Rankin

September 1st 2004

NCPA Urges Corporate Payors to Ask Pointed Questions of PBMs

ByKen Rankin

September 1st 2004

...And Corporate America Seeks to Cut PBMs Out of Loop

ByKen Rankin

August 1st 2004

Congress Considers Legislation to Streamline Rx Discount Cards...

ByKen Rankin

August 1st 2004

...But Study Finds Cards Offer Solid Savings with Generics

ByKen Rankin

August 1st 2004

PBMs Are "Practicing Medicine," Community Pharmacists Charge...

ByKen Rankin

August 1st 2004

... As State AGs Advance Their Own Rx Importation Proposal

ByKen Rankin

July 1st 2004

Neurology Academy Does End Run Around FDA

ByKen Rankin

July 1st 2004

FDA Sends Plan B Back to the Drawing Board

ByKen Rankin

July 1st 2004

Medicare Officials Report Big Savings from Rx Discount Cards

ByKen Rankin

July 1st 2004

Legislators Seek to Curb Closed Rx Networks

ByKen Rankin

July 1st 2004

Economist Warns Against "Euro" Regulation of US Pharmacies

ByKen Rankin

July 1st 2004

Opposition to Rx Importing Softens...

ByKen Rankin

July 1st 2004

FDA Issues New OTC Ingredient Label Rules

ByKen Rankin

June 1st 2004

Ohio Prison Pharmacy Errors Draw State Investigation

ByKen Rankin

June 1st 2004

Medicare Patients Are Swamped with Rx-Discount-Card Offers

ByKen Rankin

June 1st 2004

Rx Tracking Legislation Surfaces in Congress

ByKen Rankin

June 1st 2004

Internet Rx Crackdown Should Exempt Community Pharmacies

ByKen Rankin

June 1st 2004

Senate Stirs Up Debate Over Canadian Rx Importation

ByKen Rankin

June 1st 2004

FDA Launches New Online Rx Resource for Pharmacists

ByKen Rankin

May 1st 2004

Rx Importation Controversy Heats Up in Washington

ByKen Rankin

May 1st 2004

Ken Rankin

Articles by Ken Rankin

"Reverse Copay" Arrangements Gain Ground Among Rx Payers

Employers Are Suspicious of PBM Rx Strategies, NCPA Finds

Customs & FDA Cannot Keep Up With Rx Imports, GAO Warns

E-Prescribing Legislation Wins Praise from Chain Drug Stores

Fake "Canadian Generics" Are Promoted On-Line

Independent Pharmacies Show Rising Sales and Profit Margins

Vermont to Sue FDA Over Prescription Import Curbs

Illinois Pharmacists Fume over State's Mail-Order Rx Rules

Rx Vending Machines Make a New England Beachhead

Maine Rx Monitoring Program Targets Suspicious Prescribing

NCPA Urges Corporate Payors to Ask Pointed Questions of PBMs

...And Corporate America Seeks to Cut PBMs Out of Loop

Congress Considers Legislation to Streamline Rx Discount Cards...

...But Study Finds Cards Offer Solid Savings with Generics

PBMs Are "Practicing Medicine," Community Pharmacists Charge...

... As State AGs Advance Their Own Rx Importation Proposal

Neurology Academy Does End Run Around FDA

FDA Sends Plan B Back to the Drawing Board

Medicare Officials Report Big Savings from Rx Discount Cards

Legislators Seek to Curb Closed Rx Networks

Economist Warns Against "Euro" Regulation of US Pharmacies

Opposition to Rx Importing Softens...

FDA Issues New OTC Ingredient Label Rules

Ohio Prison Pharmacy Errors Draw State Investigation

Medicare Patients Are Swamped with Rx-Discount-Card Offers

Rx Tracking Legislation Surfaces in Congress

Internet Rx Crackdown Should Exempt Community Pharmacies

Senate Stirs Up Debate Over Canadian Rx Importation

FDA Launches New Online Rx Resource for Pharmacists

Rx Importation Controversy Heats Up in Washington

Trending on Pharmacy Times

Fall 2025 Quiz: Test Your Pharmacy Knowledge!

FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms

Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health

Menopause Care Varies by Provider, Highlighting Need for Standardized Education

New Data Show Elinzanetant Is a Safe, Well-Tolerated Non-Hormonal Therapy for Menopausal Vasomotor Symptoms